19 June 2013
Keywords: merck, kgaa, gets, lpath, asonep, deal, worth
Article | 03 November 2008
San Diego, USA-headquartered Lpath, a developer of lipid-based therapeutics, has entered a worldwide alliance with Germany's Merck KGaA
to develop ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 November 2008
© 2013 thepharmaletter.com